Fate Therapeutics, Inc. (FATE) Social Stream



Fate Therapeutics, Inc. (FATE): $3.43

0.22 (-6.03%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add FATE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#259 of 358

in industry

FATE THERAPEUTICS INC (FATE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering FATE THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 15 $145 $60 $107.4 $3.77 2748.81%
2021-12-14 16 $145 $60 $107.4 $3.77 2748.81%
2021-12-15 16 $145 $60 $106.666 $3.77 2729.34%
2022-01-11 16 $135 $60 $103.866 $3.77 2655.07%
2022-02-01 16 $135 $52 $103.2 $3.77 2637.4%
2022-02-07 17 $135 $42 $102 $3.77 2605.57%
2022-02-11 16 $135 $42 $98.75 $3.77 2519.36%
2022-03-01 15 $135 $42 $98.066 $3.77 2501.22%
2022-03-11 15 $135 $42 $95.571 $3.77 2435.04%
2022-03-22 15 $135 $42 $94.846 $3.77 2415.81%
2022-04-12 15 $135 $42 $95.071 $3.77 2421.78%
2022-04-13 15 $135 $42 $91.5 $3.77 2327.06%
2022-04-27 15 $135 $42 $88.928 $3.77 2258.83%
2022-05-05 15 $135 $42 $86.071 $3.77 2183.05%
2022-05-16 15 $135 $42 $83.714 $3.77 2120.53%
2022-05-17 15 $135 $42 $84.071 $3.77 2130%
2022-05-23 15 $135 $42 $81.071 $3.77 2050.42%
2022-06-06 16 $135 $28 $77.533 $3.77 1956.58%
2022-07-12 16 $135 $28 $75.733 $3.77 1908.83%
2022-08-04 17 $115 $28 $72.133 $3.77 1813.34%
2022-08-13 17 $115 $28 $72 $3.77 1809.81%
2022-08-18 18 $115 $28 $73.125 $3.77 1839.66%
2022-09-17 17 $115 $28 $70.8 $3.77 1777.98%
2022-10-05 19 $115 $28 $70.8 $3.77 1777.98%
2022-10-10 19 $115 $28 $69 $3.77 1730.24%
2022-11-04 19 $115 $28 $65.058 $3.77 1625.68%
2022-11-11 19 $115 $28 $62.75 $3.77 1564.46%
2022-11-21 19 $115 $28 $63.764 $3.77 1591.35%
2022-11-23 19 $115 $28 $63.882 $3.77 1594.48%
2022-12-12 19 $115 $28 $62.411 $3.77 1555.46%
2022-12-13 19 $115 $28 $62 $3.77 1544.56%
2022-12-15 20 $115 $10 $59.111 $3.77 1467.93%
2022-12-20 20 $115 $10 $56.705 $3.77 1404.11%
2023-01-05 22 $115 $10 $54.444 $3.77 1344.14%
2023-01-06 22 $115 $5.3 $35.85 $3.77 850.93%
2023-01-09 21 $115 $4 $25.076 $3.77 565.15%
2023-03-01 21 $90 $4 $18.723 $3.77 396.63%
2023-03-28 21 $90 $4 $14.311 $3.77 279.6%
2023-03-31 21 $90 $4 $14.37 $3.77 281.17%
2023-04-05 22 $90 $4 $14.238 $3.77 277.67%
2023-05-05 22 $90 $4 $14.055 $3.77 272.81%
2023-05-08 22 $90 $4 $13.888 $3.77 268.38%
2023-06-06 21 $90 $4 $13.058 $3.77 246.37%
2023-08-09 21 $90 $4 $13.058 $3.77 246.37%
2023-08-15 22 $90 $4 $12.188 $3.77 223.29%
2023-09-20 22 $16 $4 $7.611 $3.77 101.88%
2023-09-28 21 $16 $4 $7.462 $3.77 97.93%
2023-11-10 21 $16 $3 $7.118 $3.77 88.81%
2023-11-13 21 $16 $2 $6.911 $3.77 83.32%
2023-11-20 21 $16 $2 $6.781 $3.77 79.87%
2023-11-29 22 $16 $2 $6.676 $3.77 77.08%
2023-12-14 21 $16 $2 $6.468 $3.77 71.56%

The Trend in the Analyst Price Target


FATE's average price target has moved down $12.25 over the prior 46 weeks.

Over the past 48 weeks, FATE's average upside potential has been 232.56%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-09 22 115 4 29.516 5.27 460.08%
2023-01-09 21 115 4 25.076 5.27 375.83%
2023-01-26 21 90 4 18.723 5.30 253.26%
2023-08-09 21 90 4 13.058 3.40 284.06%
2023-09-28 21 16 4 7.462 2.18 242.29%

FATE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.57 6 0 13 1 1 21

The Trend in the Broker Recommendations


Over the past 16 months, FATE's average broker recommendation rating worsened by 1.1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how FATE THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 6781.83% of that group.
  • To contextualize these metrics, consider that out of all US stocks, FATE THERAPEUTICS INC's variance in analysts' estimates is lower than -6615.83% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, FATE THERAPEUTICS INC's number of analysts covering the stock is higher than 7034.48% of them.
  • In the context of stocks in the mid market cap category, FATE THERAPEUTICS INC's average analyst price target is greater than 4248.31% of them.

Stocks similar to FATE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NSTG, SGMO, and VCEL.

Is FATE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!